On June 11, 2025, Aquestive Therapeutics, Inc. held its Annual Meeting where two directors were elected, executive compensation was approved, and KPMG LLP was appointed as the independent auditor for 2025. Daniel Barber received 36,060,882 votes for, and the executive compensation proposal had 32,454,278 votes for.